| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 2.3. Medicines for other common symptoms in palliative care | No observations |
| Training CSamouge 2022 | 2.3 Medicines for other common symptoms in palliative care | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 24.2.1 For Depressive Disorders | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| Training CSamouge 2022 | 2.3 Medicines for other common symptoms in palliative care | No observations |
| WHO Model List of Essential Medicines (2021) | 2.3. Medicines for other common symptoms in palliative care | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 24.2.1. Medicines used in depressive disorders |
Others observations: Therapeutic alternatives to be reviewed (2023) This medicine has the best evidence for effectiveness and safety. |
| PAHO Strategic Fund Medicine List | 13.2. Medicines used in mood disorders | No observations |
| Peru | 7.2 For Prophylaxis | No observations |
| Colombia | 13.5 Antidepressives | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| List | Section | Observation |
|---|---|---|
| Training CSamouge 2022 | 2.3 Medicines for other common symptoms in palliative care | No observations |
| WHO Model List of Essential Medicines (2021) | 2.3. Medicines for other common symptoms in palliative care | No observations |
| WHO Model List of Essential Medicines (2021) | 24.2.1. Medicines used in depressive disorders |
Others observations: Therapeutic alternatives to be reviewed (2023) |
| List | Section | Observation |
|---|---|---|
| Cuba | 24.2.1.1 Antidepresivos tricĂclicos | No observations |